Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02939963
Other study ID # 69HCL16_0411
Secondary ID 2016-A01172-49
Status Completed
Phase N/A
First received
Last updated
Start date August 23, 2017
Est. completion date October 5, 2018

Study information

Verified date November 2018
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients who are intubated and mechanically ventilated for acute respiratory failure in the Intensive Care Unit (ICU) are at some point eligible for weaning. The common way to wean them from mechanical ventilation is to screen criteria for feasibility and, if present, to test feasibility by performing spontaneous breathing trial. This latter can be done either by setting a low pressure support level (expected to compensate the airflow resistance due to endotracheal tube) or by allowing the patient to breathe spontaneously through the tube without any support from the ventilator. Combination of low pressure assistance strategy (7 cm H2O) and positive expiratory pressure (PEP) of 4 cm H2O is the strategy used in our unit. Such a low pressure support level should actually result in a real assistance and, hence this is not the real spontaneous breathing capacity that is tested. Some ICU ventilators offer the option of compensating for the airflow resistance due to endotracheal tube, automatic tube compensation (ATC). Therefore, investigators aimed at comparing in patients ready to wean the usual procedure in our ICU and the ATC mode. In the ATC arm, the patients are breathing spontaneously through the endotracheal tube and are connected to the ventilator set at inspiratory pressure support of 0 cm H2O, PEP 4 cm H2O and ATC on.

Two parallel arms depending on the order of allocation of each mode: pressure support 7 cm H2O + PEP 4 cm H2O then ATC or the opposite. The primary endpoint is the power of the work of breathing. The hypothesis is that the power of the work of breathing is greater in ATC than in the usual procedure, and hence this latter is a real ventilator support.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date October 5, 2018
Est. primary completion date October 5, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- age 18 years or more

- intubated and mechanically ventilated for at least 24 consecutive hours

- staying in the medical ICU at the Croix Rousse Hospital, Lyon, France

- pressure support ventilation 10-15 cm H2O, total respiratory rate 25-35 breaths/min, expired tidal volume 6-8 ml/kg predicted body weight

- meeting criteria for spontaneous breathing trial (able to answer simple questions, no ongoing intravenous sedation, norepinephrine = 1 mg/H, dobutamine = 20 mg/h, fraction of inspired oxygen (FIO2 = 50%), PEP = 5 cm H2O, respiratory rate = 35 breaths/min, saturation in oxygen (SpO2) =88%)

- under Dräger Evita XL ou V500 ICU ventilator

- agreement to participate from the patient or next of kin

Exclusion Criteria:

- Chronic respiratory failure under long term home oxygen therapy and/or non invasive ventilation before ICU admission

- Tracheotomy

- nasogastric tube contra-indicated

- thoracic tube in place

- no agreement to participate

- under justice protection

- deprived of freedom

- pregnant or breastfeeding

- not affiliated to social insurance

- involved into another study that may interfere with present study

Study Design


Intervention

Procedure:
ATC then pressure support 7 cm H2O PEP 4 cm H2O
spontaneous breathing through endotracheal tube with no ventilator support except for ATC, the patient is connected to the ventilator with pressure support 0 cm H2O and PEP 4 cm H2O during 30 minutes then 30 minutes of basal pressure support then 30 minutes with pressure support 7 cm H2O PEP 4 cm H2O
Pressure support 7 cm H2O PEP 4 cm H2O then ATC
30 minutes with pressure support 7 cm H2O PEP 4 cm H2O then 30 minutes of basal pressure support then 30 minutes with spontaneous breathing through endotracheal tube with no ventilator support except for ATC, the patient is connected to the ventilator with pressure support 0 cm H2O and PEP 4 cm H2O

Locations

Country Name City State
France Hôpital de la Croix Rousse Lyon

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary the power of work of breathing the work of breathing is measured from the area subtended by the esophageal pressure - lung volume relationship. The power of work of breathing is obtained by multiplying work of breathing by the respiratory frequency and expressed in Joules/min 30 minutes after onset the ventilator strategy
Secondary Respiratory rate the respiratory rate is measured from the airflow tracing 30 minutes
Secondary tidal volume integration of airflow over time during expiration 30 minutes
Secondary intrinsic PEP deflection in esophageal pressure up to the first zero flow 30 minutes
Secondary occlusion pressure at 100 ms measured from the airway pressure at the first 100 ms after airway occlusion 30 minutes
Secondary work of breathing per liter work of breathing normalized for 1 liter tidal volume 30 minutes
Secondary Distribution of pulmonary ventilation distribution of pulmonary ventilation will be measured by the Pulmovista system 30 minutes
See also
  Status Clinical Trial Phase
Completed NCT02592512 - NIV-NAVA vs NIV-PS/PC in Respiratory Insufficiency N/A
Completed NCT00835809 - Multi Marker Approach Interest in Emergency in Acute Respiratory Insufficiency Diagnostic N/A
Recruiting NCT04791501 - Prevalence AND Outcome of Acute Hypoxemic Respiratory fAilure in CHILDren (PANDORA-CHILD)
Completed NCT03358043 - Prevalence and Outcome of Acute Hypoxemic Respiratory Failure in Wales
Completed NCT01931228 - Mechanical Insufflation-Exsufflation in Preventing Post Extubation Respiratory Failure in Patient With Critical Care Neuromyopathy N/A
Completed NCT03145974 - Prevalence and Outcome of Acute Hypoxemic Respiratory Failure
Completed NCT01901497 - Pharmacokinetics of Nebulized Amikacin in Non Invasive Ventilated Healthy Volunteers. N/A
Completed NCT00686257 - Evaluation Of The Total Face Mask For Emergency Application In Acute Respiratory Failure N/A
Completed NCT04346693 - An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19 Phase 3